There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

Louisiana is suing Homeland Security Secretary Alejandro Mayorkas and various agencies after state officials said an undocumented Chinese immigrant may have exposed hundreds of people to a “rare, ...

A proportion of patients with drug-resistant tuberculosis (TB) receive ineffective treatment due to misdiagnosis by rapid molecular tests, according to a genomic analysis carried out in southern ...

Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.

A recent international study found alarmingly high levels drug-resistant strains of tuberculosis (TB) in a number of countries. Researchers from the Centers for Disease Control and Prevention (CDC) ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. SAN DIEGO (FOX 5/KUSI) — Anyone who attended ...

When the antibiotic bedaquiline was introduced in 2012, it was the first new tuberculosis drug in over 40 years. Bedaquiline quickly became the key drug in all standard drug-resistant tuberculosis ...

In the search for shorter, effective, and safe regimens to treat fluoroquinolone-susceptible, rifampin-resistant tuberculosis (TB), three 9-month regimens incorporating newer and repurposed drugs ...